Frequency of Occurrence and Risk Factors of Postoperative Nausea and Vomiting During Elective C-section Under Spinal Anesthesia With Preventive Medication

Launched by UNIVERSITY OF LIEGE · Apr 14, 2025

Keywords

ClinConnect Summary

This clinical trial is looking to understand how often women experience nausea and vomiting after having a planned cesarean section (C-section) with spinal anesthesia, especially when they receive certain preventive medications. The study aims to find out how common these issues are and what factors might increase the risk for them. Participants will be asked about their experiences with nausea and vomiting in the recovery room right after the surgery and during two follow-up visits within the first 24 hours after the C-section.

To be eligible for this trial, women must be at least 37 weeks pregnant with a single baby and require an elective C-section using spinal anesthesia. However, those who have certain medical conditions, such as severe diabetes or allergies to medications used during the procedure, won't be able to participate. If you join the study, you’ll be closely monitored, and your feedback will help improve care for future patients undergoing C-sections.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Any patient requiring elective caesarean section under spinal anesthesia, at a gestational age \>37 weeks of amenorrhea in the context of a single-fetal pregnancy.
• Exclusion Criteria:
• • Failure to understand the French language; Contraindication to locoregional anesthesia; Nausea and/or vomiting in the 24 hours preceding the procedure; Type 1 or type 2 insulin-requiring non-gestational diabetes; Allergy or contraindication to one of the products used in the usual management protocol; Severe preeclampsia; Height \<150 cm